Literature DB >> 1500447

Reversed-phase ion-pair high-performance liquid chromatographic determination of triclabendazole metabolites in serum and urine.

A Negro1, M L Alvarez-Bujidos, A I Ortiz, J C Cubría, R Méndez, D Ordóñez.   

Abstract

An ion-pair high-performance liquid chromatographic method was developed for measuring the concentrations of triclabendazole metabolites (sulphoxide and sulphone) in plasma and urine samples. The diluted biological fluids are ultrafiltered before chromatography through a 30,000 relative molecular mass cut-off filter and then injected into a C18 column. They are then isocratically eluted with a mobile phase consisting of 0.05 M phosphate buffer (pH 7.0)-acetonitrile (55:45, v/v) with addition of 1.0 mmol/l sodium decanesulphonate and monitored by ultraviolet-visible spectrophotometry at 312 nm. Recoveries over the range 0.01-9.0 micrograms/ml for triclabendazole sulphoxide and sulphone are, respectively, 91.7% and 91.6% in serum and 90.3% and 90.2% in urine. For both metabolites, the limit of detection is 10 ng/ml in both urine and serum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500447     DOI: 10.1016/0378-4347(92)80184-r

Source DB:  PubMed          Journal:  J Chromatogr


  1 in total

1.  Effect of Fascioliasis on the pharmacokinetic parameters of triclabendazole in human subjects.

Authors:  Walid H El-Tantawy; Heba F Salem; Nirmeen A S Mohammed Safwat
Journal:  Pharm World Sci       Date:  2007-01-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.